diff Infection Ferring's novel first-in-class REBYOTA is indicated for the prevention of recurrence of Clostridioides difficile infection (C. diff) in individuals 18 years of age and older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback